In 2023, global liquid biopsy market sales exceeded $1 billion. Projections indicate a substantial growth trajectory, with an anticipated average annual double-digit growth rate over the next several years. By 2028, the market’s growth will reflect significant momentum and rapid expansion during the forecast period. This is according to The Worldwide Market for Liquid Biopsy, […]
January is Cervical Health Awareness Month, a reminder that more than 95% of cervical cancer cases are attributed to the human papillomavirus (HPV), according to the World Health Organization (WHO). HPV testing is a key segment of the double-digit, multi-billion-dollar global molecular diagnostic testing market, according to the new report The World Market for Molecular […]
One of the most explored applications of molecular diagnostics is oncology, a segment with sales exceeding $6 billion in 2023, according to new data published in Molecular Diagnostics in Oncology, Genetic/Inherited Diseases, and NIPT, 2023-2028, now on sale by leading medical and diagnostic market research firm Kalorama Information. In the report, the oncology segment is […]
The global market for LIS is forecast to increase at a high single-digit compound annual growth rate (CAGR) between 2022 and 2027, reveals leading medical market research publisher Kalorama Information in the new report World Market for Laboratory Information Systems (LIS): Software, Hardware, and Implementation for Clinical Labs, 2022-2027. Advances in healthcare will function as […]
The in vitro diagnostic (IVD) industry is on track again after the disruptions of the pandemic. The overall volume of IVD procedures will rise steadily throughout most of the world, boosted by aging population trends, proliferating epidemiological patterns, increasing availability of healthcare funding, and widespread adoption of patient care strategies that emphasize early disease detection […]
In vitro diagnostics (IVDs) remain dynamic. The IVD market is a high R&D spend industry with constant innovations and routine interest from venture capital firms in diagnostic products. Nevertheless, the past few years have been very disruptive for IVDs. However, the resilient IVD industry has weathered the pandemic and is forging ahead with new technologies […]
The need for veterinary testing has grown in recent years, as the majority of U.S. households claim to have at least one pet in the family. This has created ample opportunity for the companion animal segment of the veterinary diagnostic market, which globally had sales of $2.7 billion in 2022. The findings are according to […]
There’s no debate, in vitro diagnostics (IVDs) comprise a dynamic international industry with years of growth still ahead. The market already has more than $124 billion in worldwide sales and a presence in more than 20 key healthcare and medical segments ranging from molecular microbiology to infectious disease immunoassays to point-of-care (POC) to clinical chemistry. […]
Molecular point-of-care (mPOC) is a multi-billion dollar market with expanding international intrigue. Though the mPOC market is led by North America and Europe, the Asia-Pacific region makes up 10% of the market’s worldwide sales, with China positioned as a burgeoning power within the APAC. Kalorama Information, a leading medical market research firm, covers mPOC’s global […]
Where the pets go, so go the profits. This is true not just for mainstream pet products (such as food and toys) or services (such as grooming and boarding), but extends to veterinary pet healthcare, most notably veterinary diagnostic testing. Indeed, the global veterinary diagnostic market is forecast to grow to approximately $5.8 billion in […]
